FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13738311000001101: Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49006101000001113 Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111561801000001110 Mirtazapine 15mg orodispersible tablets (Advanz Pharma) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has excipient Aspartame false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Is a Mirtazapine 15mg orodispersible tablets 30 tablet true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Is pack of Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has active ingredient Mirtazapine false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has AMP Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start